文献速递胸部肿瘤放疗放疗物理与技术

非小细胞肺癌放疗疗程中解剖变化及其对调强放疗与被动散射质子治疗的影响

Anatomic change over the course of treatment for non-small cell lung cancer patients and its impact on intensity-modulated radiation therapy and passive-scattering proton therapy deliveries.
PubMed 文献 · Radiat Oncol · 2020-03-05

本研究对32例接受调强放疗(IMRT)或被动散射质子治疗(PSPT)的非小细胞肺癌(NSCLC)患者每周行4D CT,用形变配准量化靶区解剖变化。结果显示CTV相对计划CT的平均变化每周增加1.77 mm,且需自适应放疗(ART)者变化更大(8.93±2.19 mm vs 5.90±2.33 mm,p=0.001),提示靶区变化可超过常规治疗外扩边界。

要点

  • NSCLC放疗中CTV相对计划CT的平均变化每周增加1.77 mm(p<0.001)。
  • 需ART者CTV平均变化8.93±2.19 mm,显著大于非ART者5.90±2.33 mm(p=0.001)。
  • IMRT与PSPT组间CTV平均变化无显著差异(7.61±2.80 mm vs 7.21±2.67 mm,p=0.679)。

核心结论

  • 靶区体积随时间的变化幅度可大于常规治疗外扩边界,平均靶区变化可用于识别可能需要ART的肺癌患者。

研究设计与样本

  • 32例NSCLC患者(IMRT用/不用ART各8例,PSPT用/不用ART各8例),治疗期间每周获取4D CT,用自研形变配准算法配准至计划CT。
  • 解剖变化量化为ROI内所有体素形变向量幅度的平均值相对计划CT的平均变异。
  • 采用独立t检验比较按ART状态和治疗方式分组的GTV与CTV平均变化,用逻辑回归分析解剖变化对ART采纳概率的影响。

主要发现

  • IMRT与PSPT患者的时间平均CTV变化无显著差异(7.61±2.80 mm vs 7.21±2.67 mm,p=0.679)。
  • 不考虑治疗方式时,ART患者与非ART患者的CTV平均变化有显著差异(8.93±2.19 mm vs 5.90±2.33 mm,p=0.001)。
  • 所有患者CTV相对计划CT的平均变化显著增加(p<0.001),变化速率为每周1.77 mm。
  • GTV变化结果与CTV相似。
  • 逻辑回归模型正确预测71.9%的ART采纳病例,PSPT组相关性更强(伪R²=0.782),IMRT组伪R²=0.182。

关键数值与推荐

  • IMRT组时间平均CTV变化7.61±2.80 mm,PSPT组7.21±2.67 mm(p=0.679)。
  • ART组CTV平均变化8.93±2.19 mm,非ART组5.90±2.33 mm(p=0.001)。
  • 所有患者CTV平均变化速率每周1.77 mm(p<0.001)。
  • 逻辑回归模型正确预测ART采纳的准确率为71.9%。
  • PSPT组伪R²=0.782,IMRT组伪R²=0.182。

临床怎么用

  • 可利用治疗期间平均靶区变化识别可能需要ART的NSCLC患者。
  • 靶区变化可超过常规治疗外扩边界,应关注疗程中解剖变化对剂量覆盖的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To quantify tumor anatomic change of non-small cell lung cancer (NSCLC) patients given passive-scattering proton therapy (PSPT) and intensity-modulated radiation therapy (IMRT) through 6-7 weeks of treatment, and analyze the correlation between anatomic change and the need to adopt adaptive radiotherapy (ART). MATERIALS AND METHODS: Weekly 4D CT sets of 32 patients (8/8 IMRT with/without ART, 8/8 PSPT with/without ART) acquired during treatment, were registered to the planning CT using an in-house developed deformable registration algorithm. The anatomic change was quantified as the mean variation of the region of interest (ROI) relative to the planning CT by averaging the magnitude of deformation vectors of all voxels within the ROI contour. Mean variations of GTV and CTV were compared between subgroups classified by ART status and treatment modality using the independent t-test. Logistic regression analysis was performed to clarify the effect of anatomic change on the probability of ART adoption. RESULTS: There was no significant difference (p = 0.679) for the time-averaged mean CTV variations from the planning CT between IMRT (7.61 ± 2.80 mm) and PSPT (7.21 ± 2.67 mm) patients. However, a significant difference (p = 0.001) was observed between ART (8.93 ± 2.19 mm) and non-ART (5.90 ± 2.33 mm) patients, when treatment modality was not considered. Mean CTV variation from the planning CT in all patients increases significantly (p < 0.001), with a changing rate of 1.77 mm per week. Findings for the GTV change was similar. The logistic regression model correctly predicted 71.9% of cases in ART adoption. The correlation is stronger in the PSPT group with a pseudo R2 value of 0.782, compared to that in the IMRT group (pseudo R2 = 0.182). CONCLUSION: The magnitude of target volume variation over time could be greater than the usual treatment margin. Mean target volume variation from the planning position can be used to identify lung cancer patients that may need ART.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Chen M, Yang J, Liao Z, et al. Anatomic change over the course of treatment for non-small cell lung cancer patients and its impact on intensity-modulated radiation therapy and passive-scattering proton therapy deliveries. Radiat Oncol. 2020. PMID: 32138753. doi:10.1186/s13014-020-01503-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。